by Vora Corporate Finance | Dec 30, 2024 | Insights
The International Monetary Fund (IMF) upgraded India’s GDP projections by 20 basis points to 7 percent, from previous estimate of 6.8 percent in April, reflecting carryover from upward revisions to growth in 2023 and improved prospects for private consumption,...
by Vora Corporate Finance | Dec 20, 2024 | Insights, Merger & Acquisitions
Transaction: Metropolis Healthcare Limited, India’s second-largest pathology chain acquires 100% stake in oncology-focused diagnostic services provider Core Diagnostics for Rs 246.8 Crore. The acquisition will take place through a combination of cash and stock, with...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Merger & Acquisitions
Transaction: Ahead of the merger, Aster will purchase a 5.0% stake in Quality Care from Blackstone and TPG in consideration of primary share issuance by Aster for a 3.6% stake. Post the initial share acquisition, Quality Care will be merged into Aster by way of a...
by Vora Corporate Finance | Dec 16, 2024 | Insights
The BSE Sensex closed at 79,803 up by 0.52% and the Nifty 50 closed at 24,131 down by 0.31% in November 2024, driven by concerns over stretched valuations, weak performance by Indian Inc in Q2 and persistent selloffs by foreign investors. From a sector perspective,...
